within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AB38_AndexanetAlfa;
model AndexanetAlfa 
   extends Pharmacolibrary.Drugs.ATC.V.V03AB38;

  annotation(Documentation(
    info ="<html><body><p>Andexanet alfa is a recombinant modified human factor Xa decoy protein used to reverse the anticoagulant effects of direct and indirect factor Xa inhibitors, such as apixaban and rivaroxaban, in cases of life-threatening or uncontrolled bleeding. It is approved for use in adults by the FDA.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model described for healthy adult volunteers following intravenous bolus followed by continuous infusion.</p><h4>References</h4><ol><li><p>Heo, YA (2018). Andexanet Alfa: First Global Approval. <i>Drugs</i> 78(10) 1049–1055. DOI:<a href=&quot;https://doi.org/10.1007/s40265-018-0940-4&quot;>10.1007/s40265-018-0940-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29926311/&quot;>https://pubmed.ncbi.nlm.nih.gov/29926311</a></p></li><li><p>Lu, G, et al., &amp; Conley, PB (2017). Preclinical safety and efficacy of andexanet alfa in animal models. <i>Journal of thrombosis and haemostasis : JTH</i> 15(9) 1747–1756. DOI:<a href=&quot;https://doi.org/10.1111/jth.13768&quot;>10.1111/jth.13768</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28682477/&quot;>https://pubmed.ncbi.nlm.nih.gov/28682477</a></p></li><li><p>Hu, TY, et al., &amp; Asirvatham, SJ (2016). Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab. <i>Vascular health and risk management</i> 12 35–44. DOI:<a href=&quot;https://doi.org/10.2147/VHRM.S89130&quot;>10.2147/VHRM.S89130</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26937198/&quot;>https://pubmed.ncbi.nlm.nih.gov/26937198</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end AndexanetAlfa;
